Equetro Shire Pharmaceuticals Group plc - Treatment for Bipolar Disorder
Equetro, previously known as SPD417, is indicated for the treatment of acute manic and mixed episodes associated with Bipolar I Disorder. Equetro will be available for prescribing in the US in the first quarter of 2005.Posted: December 2004
Equetro (carbamazepine) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
